EUVIMEDEUVIMED entdecken
Crossref

Exploring issues and opportunities in the development of platform technologies for oligonucleotide manufacturing

Jeske Smink

Nucleic Acid Insights · 2024

DOI: 10.18609/nai.2024.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, 2024. Verfasst von Jeske Smink.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

David McCall, Senior Editor, Nucleic Acid Insights, speaks to Jeske Smink, Senior Director, Head of Drug Substance, about Silence Therapeutics’ platform-based approach to developing targeted short interfering RNA-based therapies. They discuss the current state-of-the-art in oligonucleotide manufacturing and CMC, and explore the emerging alternatives to the traditional solid-phase synthesis approach.

Zitieren

APA

Smink, J. (2024). Exploring issues and opportunities in the development of platform technologies for oligonucleotide manufacturing. Nucleic Acid Insights. https://doi.org/10.18609/nai.2024.023

Vancouver

Smink J. Exploring issues and opportunities in the development of platform technologies for oligonucleotide manufacturing. Nucleic Acid Insights. 2024. doi:10.18609/nai.2024.023

BibTeX
@article{Smink2024,
  author = {Smink, Jeske},
  title = {Exploring issues and opportunities in the development of platform technologies for oligonucleotide manufacturing},
  journal = {Nucleic Acid Insights},
  year = {2024},
  doi = {10.18609/nai.2024.023}
}
Kostenlos starten →